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Abstract  
One major unmet clinical need in epilepsy is the identification of therapies to prevent or arrest 
epilepsy development in patients exposed to a potential epileptogenic insult. The development of 
such treatments has been hampered by the lack of non-invasive biomarkers that could be used to 
identify the patients at-risk, thereby allowing to design affordable clinical studies. Our goal was to 
test the predictive value of cognitive deficits and brain astrocyte activation for the development of 
epilepsy following a potential epileptogenic injury. We used a model of epilepsy induced by 
pilocarpine-evoked status epilepticus (SE) in 21-day old rats where 60-70% of animals develop 
spontaneous seizures after around 70 days, although SE is similar in all rats. Learning was 
evaluated in the Morris water-maze at days 15 and 65 post-SE, each time followed by proton 
magnetic resonance spectroscopy for measuring hippocampal myo-Inositol levels, a marker of 
astrocyte activation. Rats were video-EEG monitored for two weeks at seven months post-SE to 
detect spontaneous seizures, then brain histology was done. Behavioral and imaging data were 
retrospectively analysed in epileptic rats and compared with non epileptic and control animals. Rats 
displayed spatial learning deficits within three weeks from SE. However, only epilepsy-prone rats 
showed accelerated forgetting and reduced learning rate compared to both rats not developing 
epilepsy and controls. These deficits were associated with reduced hippocampal neurogenesis. myo-
Inositol levels increased transiently in the hippocampus of SE-rats not developing epilepsy while 
this increase persisted until spontaneous seizures onset in epilepsy-prone rats, being associated with 
a local increase in S100-positive astrocytes. Neuronal cell loss was similar in all SE-rats. Our data 
show that behavioral deficits, together with a non-invasive marker of astrocyte activation, predict 
which rats develop epilepsy after an acute injury. These measures have potential clinical relevance 
for identifying individuals at-risk for developing epilepsy following exposure to epileptogenic 
insults, and consequently, for designing adequately powered antiepileptogenesis trials. 
Keywords: biomarker, epileptogenesis, imaging, comorbidities, learning and memory, astrocytes, 
hippocampus, status epilepticus 
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Abbreviations 
ADT, afterdischarge threshold 
AUC, area under the curve 
DCX, doublecortin 
1
H-MRS, proton magnetic resonance spectroscopy 
IHC, immunohistochemistry 
mIns, myo-Inostol 
MWM, Morris water maze 
PN, postnatal day 
ROC, Receiver Operating Characteristics 
SE, status epilepticus 
TLE, temporal lobe epilepsy 
tCr, total Creatine 
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1. Introduction  
Epileptogenesis is a dynamic process of molecular, cellular and functional reorganization occurring 
in brain following precipitating events that lead to epilepsy (Pitkanen and Engel, 2014). Epilepsy is 
one of the most prevalent brain disorders affecting around 60 million people worldwide (Duncan et 
al., 2006). It is characterized by an enduring predisposition to generate spontaneous seizures often 
associated with cognitive and psychiatric comorbidities with negative social consequences. One 
major clinical need in epilepsy is to identify antiepileptogenesis treatments for preventing or 
arresting the development of the disease in patients who have been exposed to potentially 
epileptogenic brain insults, including status epilepticus (SE) (Holtkamp et al., 2005; Wagenman et 
al., 2014). The development of such treatments has been hampered by the lack of non-invasive 
biomarkers that could be used to identify the patients at-risk, thereby allowing to design affordable 
clinical studies (Engel et al., 2013; Pitkanen and Engel, 2014).  
Our main goal was to test if cognitive deficits and astrocyte activation in seizure susceptible brain 
areas, both phenomena occurring in human epilepsy (Elger et al., 2004; Vezzani et al., 2012) and 
related animal models (Kleen et al., 2012; Vezzani et al., 2011), are biomarkers of epileptogenesis, 
thus predicting who is going to develop epilepsy after an acute brain injury. We used a well 
established pilocarpine model of SE in 21 day-old rats where only a cohort of animals develops 
epilepsy (Marcon et al., 2009; Roch et al., 2002). This model mimics de novo SE in humans; SE 
is a relatively common clinical condition (10-41/100.000 population) (Betjemann and 
Lowenstein, 2015) with the majority of cases (54%) occurring in the absence of an antecedent 
diagnosis of epilepsy (Hesdorffer et al., 1998). 53 % of patients (9/17) with de novo refractory 
SE were reported to develop epilepsy (Holtkamp et al., 2005) and in children with non-febrile 
convulsive SE subsequent epilepsy occurred in 13-74% of cases (Raspall-Chaure et al., 2006).  
By focusing our analyses in the hippocampus, a key epileptogenic area in our animal model, we 
measured increased myo-Inostol (mIns) levels, a metabolite reflecting astrocyte activation (Brand et 
al., 1993) by in vivo proton magnetic resonance spectroscopy (
1
H-MRS) and cognitive deficits in 
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the Morris Water Maze (MWM), a virtual version of which was recently developed in humans 
(Barkas et al., 2012). We found that both phenomena arise in rats before the onset of epilepsy, and 
predict which animals will develop the disease with high fidelity. Our results provide a proof-of-
principle evidence of the potential predictive value of cognitive functions and mIns levels in 
seizure-prone brain areas for epilepsy development in individuals at high-risk following 
potential epileptogenic injuries. 
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Material and Methods 
2.1 Animals  
Male Sprague–Dawley rats (Charles River, Calco, Italy) at postnatal day (PN) 21 (with PN1 defined 
as the day of birth) were used. The pups were housed with their dams at constant temperature (23 
°C) and relative humidity (60%) with a fixed 12 h light–dark cycle and free access to food and 
water until weaning at PN21. Older animals were housed one per cage. For each experimental 
protocol described in Fig. 1, male pups were used from four independent litters. All experimental 
procedures were conducted in conformity with institutional guidelines that are in compliance with 
national (D.L. n.26, G.U. March 4, 2014) and international guidelines and laws (EEC Council 
Directive 86/609, OJ L 358, 1, December 12, 1987, Guide for the Care and Use of Laboratory 
Animals, U.S. National Research Council, 1996), and were reviewed and approved by the 
intramural ethical committee.  
 
2.2 Induction and analysis of status epilepticus (SE) 
Lithium chloride (3 meq/kg; Merck Sharp & Dohme, Rome, Italy) was intraperitoneally injected in 
PN20 rats, 18 h before the subcutaneous injection of pilocarpine (Marcon et al., 2009; Roch et al., 
2002) (60 mg/kg; Sigma-Aldrich, St. Louis, MO, USA). Controls were age-matched rats injected 
with lithium chloride and an equivalent volume of vehicle (phosphate-buffered saline, PBS, pH 7.4) 
instead of pilocarpine. All animals received an injection of 10% sucrose in PBS, 2 h after the onset 
of SE to improve hydration. SE was not interrupted by any drug administration.  
As in both adult and pediatric populations (DeLorenzo et al., 1995; Logroscino et al., 1997; 
Raspall-Chaure et al., 2006), the mortality rate in this SE model is relatively high. A total of 59 
rats were injected with pilocarpine, and 23 rats died within the first week after SE. One rat was 
excluded from the study since he died during electrode implantation. The remaining 35 rats 
were used in two different protocols that were run sequentially (Protocol 2, n=14 followed by 
Protocol 3, n=21; Fig. 1). Since these animals were used for longitudinal 
1
H-MRS analysis, they 
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could not be implanted with electrodes, therefore, SE was behaviorally scored by two independent 
investigators who observed rats for 6 h after pilocarpine injection. The following scores were used 
to monitor rats: score 1 (general automatisms and exploratory behavior) and score 2 (stage 5 
seizures, bilateral forelimb clonus with rearing and falling). For each score, we determined the time 
of appearance of the first sign. Retrospective score analysis was done after rats were identified as 
epileptic or non epileptic (see later): Score 1 (min), non-epileptic 5.0 ± 1.0, n=20; epileptic, 4.5 ± 
0.7, n=11; Score 2 (min), non-epileptic 12.1 ± 0.6; epileptic, 10.4 ± 0.6. The onset of SE was 
determined by the time of appearance of the second stage 5 seizure and was similar in non-epileptic 
(13.5 ± 0.6, n=20) and epileptic rats (13.2 ± 0.7, n=11): after this time stage 5 seizures similarly 
recurred in both groups for the 6 h observation period. The two investigators confirmed 
concordance of these measures in each animal at completion of the observation period.  
We used an additional cohort of rats (n=8) implanted with hippocampal electrodes at PN19 and 
injected with lithium and pilocarpine at PN20 and PN21, respectively, to determine by EEG 
analysis if SE was of similar severity and duration in all animals (Protocol 1, Fig. 1). SE onset was 
defined by the appearance of continuous spikes with amplitude >2-fold baseline and frequency 
>5Hz while the end of SE was set as the time the inter-spike interval becomes consistently >2 sec 
(Pitkanen et al., 2005). Spikes were defined as sharp waves with an amplitude at least 2-fold higher 
than the baseline and a duration of <20 msec, or as a spike-and-wave with a duration of <200 msec 
(Pitkanen et al., 2005). Electrode-implanted rats were continuously (24/7) EEG recorded from 30 
min before pilocarpine administration (to assess EEG baseline activity) until 48 h after injection. 
The EEG analysis showed that the onset of SE (16.0 ± 1.1 min), its duration (22.6 ± 0.5 h), the 
temporal distribution of spikes (Clampfit v10.0; Axon Instruments, Union City, CA, U.S.A), and 
the power spectral densities distribution of 5 frequency bands (delta: 1–4 Hz; theta: 4–8 Hz; alpha: 
8–13 Hz; beta: 13–30 Hz; gamma: 30–40 Hz; LabChart, ADInstrument Ltd, Oxford, UK) during 
the first 3 h of SE were similar in all animals (not shown). After SE monitoring, these rats were not 
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further investigated since they were only used as a “reference” group for rats where SE was 
behaviorally scored (see above). 
2.3 Detection of recurrent spontaneous seizures and afterdischarge threshold 
Rats undergoing EEG recordings (Fig. 1) were electrode implanted under general gas anesthesia 
(1.4% isoflurane in a mixture of 70% N2O-30%O2). A bipolar nickel-chrome wire-insulated 
electrode (60 μm) was implanted unilaterally randomly in the septal left or right pole of the 
hippocampus at the following coordinates from bregma: mm: anteroposterior [AP] -3.3; nose bar 
−2.5 mm, L ± 2.4 and 3 mm below dura mater(Paxinos and Watson, 2005). Moreover, a cortical 
electrode was implanted onto the somatosensory cortex in the contralateral hemisphere. The 
electrodes were connected to a multipin socket and secured to the skull by acrylic dental cement.  
In this SE model, spontaneous seizures typically develop after a latent phase of around 70 
days (Dube et al., 2001; Leroy et al., 2011). To doublecheck the duration of the latent phase in 
our experimental conditions, the 14 rats of Protocol 2 were video-EEG recorded (24/7) from 
day 60 to day 75 post-SE (Fig. 1). According to the literature evidence, spontaneous seizures 
were detected at day 68.8 ± 1.8 (2.8 ± 0.6 seizures in 2 weeks) in 5 rats, denoting that this was 
the time approaching epilepsy onset. After day 75, 3 rats still without seizures lost their EEG 
implant and one rat died during severe seizures, therefore these animals were excluded from 
this study. The 10 remaining rats were again video-EEG recorded at 7 months post-SE: 7 rats 
developed spontaneous seizures (epileptic; which includes the 5 rats already developing 
epilepsy around day 70) while 3 rats did not develop seizures (non-epileptic). Since data 
showed that the latent phase in this model lasts for at least 70 days, we carried out our 
longitudinal behavioral and MRI analyses within this time frame. 
Rats in Protocol 3 (n=21; Fig. 1) were video-EEG monitored at seven months post-SE for two 
weeks (24/7) to determine and quantify spontaneous seizures. We found that 13 out of 21 rats 
developed spontaneous motor seizures (epileptic) while the remaining 8 rats showed no 
seizures (non-epileptic). Therefore the average incidence of epilepsy in this model (5.8 ± 1.5 
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seizures in 2 weeks in Protocols 2 and 3) was between 62% and 70%, in agreement with 
previous studies where animals were recorded at least 3 months post-SE (Kubova et al., 2004; 
Marcon et al., 2009). 
We also measured the rat hippocampal afterdischarge threshold (ADT) at the end of EEG 
monitoring as a measure of local excitability. Animals were electrically stimulated via the 
hippocampal electrode, using constant current stimulus (1 msec monopolar square waves, 50 Hz for 
2 s). Determination of the ADT was done using an ascending stepwise procedure (Frigerio et al., 
2012). The initial stimulus intensity was 50 μA and was increased by 10 μA up to 100 μA, and then 
by 100 μA up to a maximal value of 400 μA by intervals of 1 min, until one AD of at least 10 sec 
duration was elicited. ADT was reduced by 50% in epileptic rats (103  18 A; n=20) compared to 
control rats not exposed to SE (220  40 A, n=9). Non-epileptic rats showed an ADT similar to 
control rats (223  22 A, n=11). AD duration did not differ among the 3 experimental groups (sec; 
control: 19.1  2.6; non-epileptic: 23.3  4.0; epileptic: 26.0  6.1). Twenty-four hours later, rats 
were killed for brain histological analysis. 
2.4 Morris water maze (MWM) 
The MWM apparatus consisted of a circular pool (diameter 150 cm, height 60 cm) filled with water, 
opaque by the addition of a brown food dye (depth 30 cm, temperature 25 ± 1°C). The circular pool 
was ideally divided in four quadrants, and a squared platform (11x11 cm) was placed 1 cm below 
the water surface in the center of one quadrants. The test was performed twice in the same rat, at 
day 15 and day 65 post-SE, unless otherwise indicated (Fig. 1). The position of the platform was 
kept in the same quadrant during the first behavioral test, then was moved to a different quadrant 
during the second exposure to the same behavioral test. Each rat underwent one training session per 
day, which included four swims; daily training sessions were done for five consecutive days. 
During each training session, rats were placed into the pool starting from each of the four quadrants 
(north, west, south and east) with the head facing towards the wall of the pool. The escape latency, 
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i.e. the time to reach the hidden platform, was measured. Each rat was allowed to swim until the 
platform was found or rat had swum unsuccessfully for 60 sec. In the latter case, the rat was guided 
to the platform by the investigator and its escape latency was recorded as 60 sec. After 10 sec rest 
on the platform, the rat was transferred into its home cage. Rat movements were monitored by a 
video camera connected to a digital tracking device (Noldus, Ethovision, The Netherlands). 
 
2.5 
1
H-MRS analysis and spectra quantification 
Animals were imaged at day 22 and day 72 post-SE, i.e., seven days after the MWM test (Fig. 1), 
under general gas anesthesia (1.4% isoflurane in a mixture of 70% N2O-30%O2). Respiratory rate 
and temperature were continuously monitored. Experiments were done on a 7T Bruker Biospin 
70/30 Avance III system, equipped with a 12 cm diameter gradient coil (400 mT/m maximum 
amplitude). A transmit cylindrical radiofrequency (rf) coil (7.2 cm inner diameter) and a receive 
surface rf (2 x 2 cm) coil array positioned over the animal head were used. Localized proton 
spectroscopy was performed as previously described (Filibian et al., 2012). Briefly, a PRESS (Point 
Resolved Spectroscopy) sequence (repetition time TR/TE=2500/10 ms, 512 scans, spectral width 20 
ppm, 8192 points) was carried out in a single voxel (14 µL) positioned randomly in the septal left or 
right pole of the hippocampus. Water suppression was performed with VAPOR and first and second 
order shims were adjusted using FASTMAP (Fast, Automatic Shimming technique by Mapping 
Along Projections). 
1
H-MRS spectra were quantified using TARQUIN 4.2.1 (Wilson et al., 2011) 
for the estimation of mIns levels. Each spectrum was pre-processed by applying automated zero-
order phasing and referencing, and by performing residual water line removal with the HSVD 
method. The processed signal was fit to a linear combination of selected metabolites. The reliability 
and quality of the fitting procedure was assessed both by visual inspection and by checking the 
quality parameter Q retrieved by TARQUIN. The mean value of Q was included between 1.15 and 
1.3, indicating a very high fit quality (Q=1 corresponds to a perfect fit)(Wilson et al., 2011). The 
amplitudes of the mIns signals obtained by the fit that had a CRLB (Cramer-Rao lower bound) 
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higher than 35% were excluded from the results. Relative mIns levels were then derived by scaling 
the fitted amplitudes by the amplitude of the total Creatine (tCr: Cr + phospho Cr) signal, 
considered as the internal standard. 
 
2.6 Tissue preparation for immunohistochemical analysis 
Twenty-four hours after measuring the ADT, rats were deeply anaesthetized using ketamine (150 
mg/kg) and medetomidine (2.0 mg/kg) and perfused via ascending aorta as previously described 
(Marcon et al., 2009). The brains were post-fixed for 90 min at 4° C, transferred to 20% sucrose in 
PBS for 24 h at 4° C, frozen in n-pentane for 3 min at −50° C, and then stored at −80° C until 
assayed. Immunohistochemistry (IHC) was done to detect glia activation (S100 for astrocytes; 
OX-42 for microglia) and neurogenesis (doublecortin, DCX). Nissl staining was performed to 
assess neuronal cell loss. All the analyses were done in 6 vehicle-injected rats (controls) and 14 
pilocarpine-treated rats (n=7 epileptic; n=7 non-epileptic) randomly taken among the rats included 
in Protocols 2 and 3 (Fig. 1), except for stereological counting and neurogenesis that was done in 5 
randomly chosen rats in each group. Serial coronal sections (40 μm) were cut on a cryostat 
throughout the septo-temporal extension of the hippocampus (−2.3 to −5.8 mm from bregma) 
according to Paxinos & Watson atlas (Paxinos and Watson, 2005). We prepared 8 series of 10 
sections each (4 series including the septal and 4 series including the temporal aspect of the 
hippocampus). In each serie, the 1
st
 and 5
th
 sections were stained for Nissl. In the 1
st
, 3
th
, 6
th
 and 8
th
 
series, the 2
th
 section was stained for S100, the 3rd for OX-42 and the 4th for DCX. S100, OX-42 
and DCX immunostaining was carried out as previously described (Filibian et al., 2012; Iori et al., 
2013). We previously established lack of signal when slices were incubated with the primary 
antibodies preabsorbed with the corresponding peptides, or without the primary antibodies. 
Immunohistochemical analysis of brain sections (plates 19-22) (Paxinos and Watson, 2005) and 
quantification procedures were performed by two independent expert investigators blind to the 
identity of the samples. 
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Neuronal cell loss was quantified by reckoning the number of Nissl-stained neurons in CA1 and 
CA3 pyramidal cell layers and the hilar interneurons using an image of the whole hippocampus 
captured at 20X magnification (Virtual Slider Microscope; Olympus, Germany) and digitized (n=6 
control; n=7 epileptic; n=7 non-epileptic; 4 slices/rat). In addition, stereological analysis in Nissl-
stained sections was performed (n=5 each group; 3 slices/rat). The nucleoli of pyramidal neurons 
(CA1 and CA3) and hilar interneurons were counted at 40X magnification using an Eclipse E600 
microscope equipped with Optronics MicroFire digital camera (Nikon, Japan). The neuronal density 
was estimated with the Optical Fractionator technique, using a computer-assisted microscope and 
the StereoInvestigator software (MicroBrightField), as previously described (Spigolon et al., 2010). 
A 4 µm guard zone, a 50 µm x 50 µm counting frame size and a 100 µm x 100 µm grid layout were 
employed.  
Data obtained in both hippocampi in each rat were averaged, thus providing a single value for each 
rat, and this value was used for the statistical analysis.  
The total number of S100-immunoreactive astrocytes was counted in the whole hippocampus (20X 
magnification) by an investigator who visually identified the cells; then an automated cell count was 
generated using ImageJ software (n=6 control; n=7 epileptic; n=7 non-epileptic; 2 slices/rat).  
OX-42-immunostained area was measured in the whole hippocampus (20X magnification) using 
ImageJ software, and data were expressed as positive pixels/total assessed pixels; the percent area 
with the specific staining was used for subsequent statistical analysis (n=6 control; n=7 epileptic; 
n=7 non-epileptic; 2 slices/rat).  
The analysis of DCX-immunostained sections (n=5 rats each group; 4 slices/rat) was performed 
using a Zeiss slide scanner (Axioscanner Z1, Zeiss, Germany) and a Zeiss ZEN2 software (v1.0 EN 
1.0) at 5X, 10X and 20X magnifications, and each hippocampus was reconstructed into a tiled 
image using Zeiss software. DCX-positive cells in the subgranular zone were counted in each 
dentate, as previously described (Zaben et al., 2009). For Sholl analysis, one DCX-stained 
cell/dentate blade/dentate/section was randomly chosen and the dendritic tree was analysed using 
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ImageJ software (FIJI, v2.0.0-rc-43/150e) with the Simple Neurite Tracer Plug-in. Sholl analysis 
was confined to DCX-positive cells with a dendritic tree extending into the molecular layer. 
Dendritic processes were semi-automatically traced in ImageJ (v1.49, NIH), and the number of 
dendritic intersections across concentric Sholl circle radii rings at intervals of 10 µm was recorded.  
 
2.7 Randomization, blinding procedures and statistical analysis of data  
Sample size was a priori determined based on previous experience with the animal model and the 
respective behavioral and imaging analyses. Simple randomization was applied to assign a 
subject to a specific experimental group (vehicle or pilocarpine treatment) using a web site 
randomization program (http://www.randomization.com). One day after vehicle or 
pilocarpine injection, rats were linked to numerical identifiers by an external investigator not 
involved in the study and unaware of the treatment. This procedure ensured that animal 
handling and data acquisition during the longitudinal analyses were done by investigators 
blinded to the identity of the animals. After epileptic and non-epileptic rats were identified 
based on the presence of spontaneous seizures at 7 months, the external investigator 
generated two randomization tables (http://www.randomization.com) one for Protocol 2 and 
one for Protocol 3, in order to assign the rats in each experimental group to the investigators 
blinded to the animal identity for carrying out the immunohistochemical analysis. Un-linkage 
was done at completion of all the analyses. Data are expressed as mean ± s.e.m. (n= number of 
individual samples). Statistical analysis was performed by Graph-Pad Software using absolute 
values. Data related to myo-Ins/tCr level, ADT, IHC measures, escape latency in a specific testing 
day, and Sholl analysis were analyzed by one-way ANOVA followed by Dunn’s post-hoc test. 
Mann–Whitney test was used to analyse the combination of biomarkers. The overall analysis of the 
data related to the escape latency during the 5 days of training was done by two-ways ANOVA for 
repeated measurements. The performance of biomarkers was assessed using non parametric 
Receiver Operating Characteristics (ROC) curves: the area under the curve (AUC) was calculated 
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and compared with chance (AUC=0.5). The performance of the biomarker is considered excellent 
for AUC values close to 1. Differences were considered significant with a p<0.05.  
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2. Results 
After grouping the animals at 7 months post-SE in epileptic and non-epileptic rats, based on the 
presence of spontaneous seizures and the ADT, we retrospectively analysed and compared their 
behavioral performance in the MWM (Fig. 2) and their respective mIns levels by 
1
H-MRS 
 
(Fig. 3) 
that were both assessed before the predicted time of epilepsy onset.  
 
3.1 Evaluation of animal performance in Morris Water Maze  
During the 5 days of training, the overall statistical analysis indicates that the three experimental 
groups (control, non-epileptic and epileptic rats) performed differently both at day 15 (Fig. 2A) and 
at day 65 (Fig. 2D) post-SE [Group x Trial interaction: day 15: F(8,236)=1.95, p<0.05; day 65: 
F(8,200)=1.98, p<0.05]. At day 15, all rats learned to find the hidden platform independently of the 
experimental group, as indicated by the progressive reduction in the escape latency over the 5 
training days (Fig. 2A). However, epileptic and non-epileptic rats had a 2-fold longer escape latency 
on average than controls in trials 3 and 4 (Fig. 2A; p<0.05). In trial 5, this deficit was maintained 
only in epileptic rats (Fig. 2A; p<0.05). In accordance, the escape latency did not improve during 
the last 3 trials in epileptic rats (p<0.05 vs both control and non-epileptic rats). Epileptic rats also 
showed a slower rate of learning (p<0.05) compared to non-epileptic rats and controls (Fig. 2B). 
The ROC curve obtained by comparing the rate of learning of epileptic vs non-epileptic rats showed 
an AUC=0.79 (p=0.01; Fig. 2C). At day 65 post-SE, the learning performance of the three 
experimental groups was similar to day 15 (Fig. 2D vs A). Notably, a new behavioral feature was 
specifically observed in epileptic rats: comparison of the escape latency of the last training session 
of each day with the escape latency of the first training session of the subsequent day showed that 
epileptic rats had a poor overnight memory retention (i.e., accelerated forgetting) compared to non-
epileptic rats, a phenomenon developing over the 5 day trials (Fig. 2E). The correspondent ROC 
curve had an AUC value of 0.84 (p=0.009; Fig. 2F). In SE-exposed rats, we did not observe any 
clinical seizure during the training period. 
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3.2 
1
H-MRS analysis of mIns 
One week after the end of each behavioral test, all rats underwent 
1
H-MRS analysis in the dorsal 
hippocampus for measuring mIns levels (Fig. 3). At day 22, mIns/tCr levels increased by 20% on 
average in both epileptic and non-epileptic rats compared to controls (0.59 ± 0.02 arbitrary unit; 
Fig. 3A-C, G). At day 72, this increase persisted only in epileptic rats (Fig. 3F,G) while mIns/tCr 
levels declined in non-epileptic rats to control levels (Fig. 3E,G). The ROC curve comparing 
epileptic vs non-epileptic rats at day 72 showed an AUC=0.83 (p=0.01).  
The accuracy of discrimination between SE-rats that will develop epilepsy from those rats not 
developing the disease was increased by reckoning the ratio between rate of learning at day 15 and 
mIns/tCr levels at day 72 (Fig. 4A) as shown by the ROC curve with an AUC= 0.9 (p=0.0027; Fig. 
4B). 
 
3.3 Brain histology 
At completion of EEG recording and ADT measurements, we analysed cell loss, glia activation and 
neurogenesis in the septal pole of the hippocampus of randomly selected rats since this area is 
especially involved in cognitive processes (Broadbent et al., 2004).  
Neuronal cell loss. A reduction of the total number of hilar interneurons (by 60% on average; 
p<0.01 vs control) and CA3 pyramidal cells (by 18% on average; p<0.05 vs control, n=6) was found 
in all SE-rats independently on whether or not they developed spontaneous seizures (Fig. 4A; n=7 
epileptic, n=7 non-epileptic). Stereological analysis confirmed that cell loss was similar in all rats 
showing around 55% reduction of hilar interneurons (p<0.05) and 40% reduction of CA3 pyramidal 
cells (p<0.01) vs controls (Fig. 5B) (n=5 each group). The number of CA1 pyramidal neurons was 
not significantly reduced in SE- rats compared to controls (Fig. 6A,B). 
Glia activation. OX-42-positive microglia showed small cell bodies and extensive ramifications 
denoting their resting state in all three experimental groups (not shown). Accordingly, the percent 
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hippocampal area occupied by the specific OX-42 signal in epileptic (10.6 ± 0.6%, n=7) and non-
epileptic (8.5 ± 1.1%, n=7) rats was similar to control rats (9.4 ± 0.8%, n=6).  
Differently, we found that the number of S100-positive astrocytes was increased by 27.1 ± 5.2% in 
epileptic rats (n=7, p<0.05) compared to controls (n=6) while no difference was found between 
non-epileptic (n=7) and control rats (Fig. 6C). 
Neurogenesis. There was an overall significant difference in the number of newly born DCX-
positive neurons in the dentate gyrus among the three experimental groups (p<0.01). A significant 
50% reduction in these cells was found in epileptic vs control rats while non-epileptic rats were 
similar to controls (Fig. 5D; n=5 each group). The dendritic arborisation of DCX-positive cells with 
dendrites extending through the granule cell and molecular layers was examined in 18 cells from 
epileptic rats, 22 cells from non-epileptic rats and 16 cells from control rats using Sholl analysis. 
The analysis of the AUC of the mean crossings per cell showed a significant effect of the group 
(p<0.01) revealing differences between epileptic and control rats (p<0.01) and non-epileptic and 
control rats (p<0.05) (Fig. 5E). Epileptic and non-epileptic rats had less complex dendritic trees, 
especially distally, with this phenomenon more marked, although not significantly, in epileptic rats 
(Fig. 5E).  
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3. Discussion 
We report the novel evidence that cognitive deficits in a spatial memory test together with astrocyte 
activation in the hippocampus, predict the development of epilepsy in a rat model of de novo SE 
with high accuracy. This model is highly valuable for determining factors associated with 
epileptogenesis since only a cohort of rats develop spontaneous seizures after an inciting event of 
similar severity and duration (Marcon et al., 2009; Roch et al., 2002). In accord, we found that only 
70% of rats developed epilepsy, although SE was similar in all rat. In support, hippocampal cell 
loss, an objective measure of SE severity (Fujikawa, 1996), did not differ among animals.  
We identified epileptic and non-epileptic rats based on the detection of video-EEG seizures at seven 
months post-SE. We monitored rats for two weeks, which allows sound seizure detection based on 
their mean frequency, i.e., one seizure every three days. Although we cannot exclude that seizures 
might have occurred at later time points in non-epileptic rats, this is unlikely based on literature 
evidence related to this model (Kubova et al., 2004). Additionally, ADT in non-epileptic and 
control rats was similar while it was significantly reduced in epileptic rats, thus supporting the lack 
of chronic excitability changes in rats without seizures.  
Our retrospective data analysis showed that SE-exposed rats developed early cognitive deficits in a 
spatial learning task. Impaired cognitive functions were previously reported to occur before 
epilepsy onset during both post-natal development (Cilio et al., 2003; Kubova et al., 2004; Liu et 
al., 1994; Sayin et al., 2004) and in adulthood (Chauviere et al., 2009; Hort et al., 2000; Jones et al., 
2010) but it was unknown whether these deficits correlated with epilepsy development. We describe 
for the first time that a reduced rate of learning and an accelerated forgetting are two specific 
features of rats prone to develop epilepsy, and these deficits anticipate the onset of spontaneous 
seizures. Notably, impaired spatial learning and accelerated forgetting were also described in 
temporal lobe epilepsy (TLE) patients exposed to a virtual MWM task (Barkas et al., 2012) and 
cognitive deficits were documented in children and adult before the first recognized seizures or at 
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the early stages of the disease (Hermann et al., 2006; Oostrom et al., 2003; Witt and Helmstaedter, 
2015). This clinical evidence highlights the high translational significance of our findings.   
Our results, together with evidence that cognitive deficits and the propensity to develop epilepsy 
after SE both increase with age (Cilio et al., 2003; Kubova et al., 2004; Sayin et al., 2004), reinforce 
the hypothesis that they share common molecular changes (Devinsky et al., 2013; Todd et al., 
2006). In this respect, we found that persistent astrocyte activation in the hippocampus is a specific 
feature of epilepsy-prone rats, as shown by longitudinal 
1
H-MRS analysis of mIns/tCr levels and by 
post-mortem analysis of S100-positive astrocytes. Similar changes in these measures were 
reported in adult rat models where all animals develop epilepsy (Filibian et al., 2012; Wu et al., 
2015; Zahr et al., 2009). Altogether, these data suggest that S100-expressing astrocytes contribute 
to the mIns changes during epileptogenesis and may play a role in both cognitive impairment and 
seizure generation. Accordingly, mice overexpressing S100 show spatial memory impairment 
(Gerlai et al., 1995) while S100 knock-out mice exhibit enhanced spatial learning in the MWM 
(Nishiyama et al., 2002). S100-induced modifications of intracellular Ca2+ in astrocytes (Barger 
and Van Eldik, 1992) and in neurons by activation of RAGE receptors (Huttunen et al., 2000) 
appear to be involved in the modulation of synaptic plasticity. S100β released by astrocytes may 
also promotes changes in neuronal rhythms that are relevant for seizure onset (Morquette et al., 
2015; Sakatani et al., 2008), and RAGE receptors areimplicated in both cognitive impairments 
(Mazarati et al., 2011) and epileptogenesis (Iori et al., 2013). In this context, there is increasing 
evidence that activated astrocytes play a key role in neuronal network hyperexcitability underlying 
seizures (Devinsky et al., 2013; Robel et al., 2015).  
Neurogenesis is another biological process implicated in cognitive dysfunctions in TLE 
(Hattiangady et al., 2004; Scharfman and Gray, 2007) and aberrant neuronal network excitability 
(Scharfman et al., 2000). In particular, a negative correlation was reported between the number of 
DCX-positive neurons in surgically resected TLE hippocampi and the memory functions in the 
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respective patients before surgery (Coras et al., 2010). Our data show that epileptic rats had reduced 
levels of dentate neurogenesis compared to controls and non-epileptic rats. Altered neurogenesis is 
present immediately after SE during epileptogenesis (Gray and Sundstrom, 1998; Parent et al., 
1997), at the time of our behavioral analysis, as well as chronically in TLE (Hattiangady et al., 
2004), and thus might contribute to the progressive cognitive impairment we observed in rats prone 
to develop epilepsy. Other cellular alterations induced by SE such as reduction in dendritic spine 
density (Jiang et al., 1998) and place cells dysfunctions (Holmes, 2015) have been associated with 
cognitive impairment (Holmes, 2015; Jiang et al., 1998) and could play a role, together with the less 
complex dendritic arborization of DCX-positive neurons in SE-rats, to the behavioral deficits that 
precede epilepsy development in our model. 
 
4. Conclusions 
This study provides the first proof-of-principle demonstration that assessment of cognitive abilities 
and 
1
H-MRS analysis of mIns in seizure-prone brain areas following potential epileptogenic 
injuries, may represent clinically meaningful biomarkers for early identification of individuals at 
high-risk for developing epilepsy (Betjemann and Lowenstein, 2015; Herman, 2002; Raspall-
Chaure et al., 2006). Although our findings are related to a model of SE-induced epilepsy, 
increased mIns brain levels were found to be associated with neurological dysfunctions in 
children and adults after traumatic brain injury (Ashwal et al., 2004; Brooks et al., 2000; 
Garnett et al., 2000), although no attempts were made to correlate these measures with 
epilepsy development. This evidence, therefore, potentially extends the significance of our 
findings to epileptogenic injuries other than SE, such as neurotrauma, ischemic stroke or CNS 
infections. If applied and validated in the clinical setting these non invasive measures could 
greatly facilitate the clinical development of novel preventive anti-epileptogenic therapies.  
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Figure legends 
Figure 1 
The schematic diagram illustrates the experimental design, the number of rats injected with 
pilocarpine (Pilo with SE) and undergoing the subsequent analyses, and the animals excluded by the 
study in each experiment. Protocol 1 refers to rats exposed to SE and used as a reference group 
to determine by EEG analysis that SE severity and duration were similar in all animals.  
Protocol 2 refers to rats tested in the MWM at day 15 post-SE then subjected to 
1
H-MRS analysis 
(day 22) and electrode implanted at day 50 for EEG analysis to detect epilepsy onset. After 
electrode implantation these rats did not undergo additional behavioral or 
1
H-MRS analyses until 
seizure detection was done at 7 months (as in Protocol 2). Protocol 3 refers to rats followed for 7 
months and longitudinally tested for cognitive behavior in the Morris Water Maze (MWM) at day 
15 and day 65 post-SE, each time followed after seven days by 
1
H-MRS analysis of mIns. After 
imaging sessions were terminated, rats were electrode implanted at day 80 post-SE for seizure 
detection at 7 months. All rats were tested for afterdischarge threshold (ADT) at the end of EEG 
recordings. Brain histology was done after animals were sacrificed at the end of the experiment. 
 
Figure 2 
Cognitive performance in Morris Water Maze during epileptogenesis  
Panel A depicts the escape latency during the 5 days of training in controls (n=33), non-epileptic 
(n=11) and epileptic rats (n=20) at day 15 post-SE. *p<0.05 vs control; #p<0.05 vs non-epileptic, 
by one-way ANOVA followed by Dunn’s test. Panel B shows the rate of learning at 15 days after 
SE: the difference between the escape latency in trials 1 and 5, normalized to the escape latency in 
trial 1. Epileptic rats showed a slower rate of learning compared to non-epileptic rats and controls 
*p<0.05 vs control; #p<0.05 vs non-epileptic by one-way ANOVA followed by Dunn’s test.  
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Panel C depicts the ROC curve obtained by comparing the rate of learning of epileptic vs non-
epileptic rats; the AUC=0.79 indicates that this parameter discriminates with good accuracy the two 
cohorts of animals. 
Panel D depicts the escape latency during the 5 days of training in controls (n=32), non-epileptic 
(n=8) and epileptic rats (n=13) at day 65 post-SE. **p<0.01 vs control; #p<0.05 vs non-epileptic, 
by one-way ANOVA followed by Dunn’s test.  
Panel E shows daily comparison during the 5 days of training of the escape latency measured during 
the last training session of each day (Trial 4) with the escape latency measured during the first 
session of the subsequent day (Trial 1) at 65 days post-SE in epileptic and non-epileptic rats. 
Epileptic rats had poorer overnight retention (i.e. accelerated forgetting) compared to non-epileptic 
rats. *p<0.05 vs trial 4 at days 3 and 4. Panel F depicts the ROC curve obtained by comparing the 
accelerated forgetting of epileptic vs non-epileptic rats; the AUC=0.84 indicates that this parameter 
discriminates with excellent accuracy the two cohorts of rats. 
 
Figure 3 
1
H-MRS analysis of mIns/tCr levels in the hippocampus during epileptogenesis 
Representative 
1
H-MRS spectra acquired at day 22 (A-C) or day 72 (D-F) post-SE in control (A,D), 
non-epileptic (B,E) and epileptic rats (C,F). Spectra and fit residuals (upper row) are plotted in blue, 
metabolite fits are plotted in green, and mIns contribution is plotted in red. Panel G depicts the 
mIns/tCr levels (mean ± s.e.m.) in the various experimental groups at day 22 (control n=9; non-
epileptic n=11; epileptic n=20) and day 72 (control n=9; non-epileptic n=8; epileptic n=13) post-
SE. At day 22, mIns/tCr levels were increased similarly in epileptic and non-epileptic rats compared 
to controls while at day 72 the mIns/tCr increase persisted only in epileptic rats. *p<0.05 vs control; 
#p<0.05 vs non-epileptic by one-way ANOVA followed by Dunn’s test. Panel H depicts the ROC 
curve obtained by comparing mIns/tCr levels in epileptic vs non-epileptic rats at day 72 post-SE; 
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the AUC=0.83 indicates that this parameter discriminate with excellent accuracy the two cohort of 
rats. 
  
Figure 4 
Improved predictivity of epilepsy by combinatorial biomarkers   
Panel A shows the ratio between the rate of learning at day 15 and the respective levels of mIns/tCr 
at day 72 post-SE in epileptic (n=13) and non-epileptic rats (n=8). *p<0.05 by Mann-Whitney’s 
test. Panel B depicts the ROC curve obtained by comparing the values shown in panel A in epileptic 
vs non-epileptic rats; the AUC=0.90 indicates that this parameter discriminate with high fidelity the 
two cohorts of animals. 
 
Figure 5 
Histological analysis of the hippocampus at 7 months post-SE in rats with and without spontaneous 
seizures 
Panels A and B depict the quantification of neuronal cells in CA1 and CA3 pyramidal layers and in 
the hilus estimated by counting the Nissl-stained neurons (A) and by stereological analysis (B) in 
control (n=5-6), non epileptic (n=5-7) and epileptic (n=5-7) rats. In control hippocampi, the number 
of neuron/section was (mean ± s.e.m., n=6) CA1: 1279  25; CA3: 546  15; hilus: 93.9  7 (A); 
cells/mm
3
 x 10
3 
(mean ± s.e.m., n=5) CA1: 159.112.1; CA3: 95.35.8; hilus: 11.21.8 (B).  
*p<0.05, **p<0.01 vs control by one-way ANOVA followed by Dunn’s test. 
Panel C shows the number of S100-immunoreactive astrocytes in control (n=6), non-epileptic 
(n=7) and epileptic (n=7) rats. The number of cells (mean ± s.e.m., n=6) in control was 1.891 ± 
139. Microphotographs in panel C depict representative images of S100-positive astrocytes in 
CA1 pyramidal cell layer in the various groups. *p<0.05 vs control, ##p<0.01 vs non-epileptic by 
one-way ANOVA followed by Dunn’s test. Scal bar: 100 m 
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Panels D depicts the quantification of DCX-positive neurons in the dentate gyrus in the various 
experimental groups (n=5 rat each group). The number of DCX cells in control was 66.8 ± 8 (mean 
± s.e.m.). **p<0.01 vs control, ##p<0.01 vs non-epileptic by one-way ANOVA followed by Dunn’s 
test. Panel E shows Sholl analysis in epileptic and non-epileptic rats showing similar 
compromission in dendrite complexity.  
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Highlights 
 cognitive deficits and astrocyte activation arise before epilepsy onset 
 accelerated forgetting and reduced learning rate both predict the development of epilepsy 
 increased hippocampal myo-Inositol levels by in vivo imaging, an indicator of astrocyte activation, 
predicts epilepsy development 
 these noninvasive measures are potentially relevant for early identification of individuals at 
high-risk for developing epilepsy 
